Praxbind TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: idarucizumab
Pack: Praxbind 2.5 g/50 mL injection, 2 x 50 mL vials
Brand name
(ARTG)
: PRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
PRAXBIND is a specific reversal agent for dabigatran and is indicated in patients treated with dabigatran etexilate (PRADAXA) when rapid reversal of the anticoagulant effects of dabigatran is required: - for emergency surgery/urgent procedures; - in life-threatening or uncontrolled bleeding.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear to slightly opalescent, colourless to slightly yellow solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 48 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 2 vials pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient idarucizumab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
